Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | CELZ | Common Stock | Options Exercise | $40K | +10M | $0.00 | 10M | Jun 28, 2021 | Direct | ||
transaction | CELZ | Common Stock | Tax liability | -$40K | -1.12M | -11.2% | $0.04 | 8.88M | Jun 28, 2021 | Direct | F1 |
holding | CELZ | Common Stock | 17.2K | Jun 28, 2021 | By LLC | F2 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | CELZ | Warrant to Purchase Common Stock | Options Exercise | $0 | -10M | -100% | $0.00* | 0 | Jun 28, 2021 | Common Stock | 10M | $0.00 | Direct |
Id | Content |
---|---|
F1 | Reflects 1,120,448 shares of common stock withheld by issuer at a market price of $0.0357 per share to fund the cashless exercise of 10,000,000 shares of common stock acquired upon exercise of the Warrant identified in Table II. |
F2 | Shares are held by BioTech Holdings, LLC, of which the reporting person is President. The reporting person disclaims beneficial ownership of such shares of common stock except to the extent of his pecuniary interest therein. |